We provide you with 20 years of free, institutional-grade data for CLSD stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of CLSD. Explore the full financial landscape of CLSD stock.
| Reported Date | CIK | Ticker | Type |
|---|
Clearside Biomedical, Inc(NASDAQ:CLSD) 
Clearside Biomedical, Inc., a biopharmaceutical company, engages in the developing and delivering treatments that restore and preserve vision for people with serious eye diseases. Its product includes CLS-AX, an axitinib for suprachoroidal injection which is in Phase 1/2a clinical trial. It also dev...
Website: http://www.clearsidebio.com
Founded: 2011
Full Time Employees: 33
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about CLSD stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.